ReviewThe Journal of infectious diseases2025
Immunoengineering: An Emerging Field in Infectious Diseases.
Review in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Innovation in antifungal therapy.EMBO molecular medicine · 2026Review
- The International Immunotherapy Society for Fungal Diseases.Antimicrobial agents and chemotherapy · 2026Article
- Implant Infectious Diseases: An Introduction to Biomaterials for ID Physicians.Open forum infectious diseases · 2025Review
- Immunotherapy for Infectious Diseases: Back to the Future.The Journal of infectious diseases · 2025Article
- Review
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
Abstract
As the disciplines of materials science, bioengineering, and immunology mature in the 21st century, the convergence science of immunoengineering has emerged as a paradigm to augment host immunity. By delivering biochemical and mechanical cues with engineered precision, the immune system can be stimulated to respond to specific antigens with a designed phenotype. While cancer has driven the early discoveries in immunoengineering, the field of infectious diseases stands to benefit tremendously by applying the concepts of immunoengineering to current clinical challenges. Antimicrobial resistance, highly communicable emerging pathogens, and infections in immunocompromised hosts are some examples of current problems that are suitable for immunoengineering approaches. Here, we will introduce basic concepts associated with immunoengineering and provide current examples applied to infectious diseases, including cell therapies, immunomodulating small molecule delivery, and next-generation vaccine development with implantable biomaterials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.